| Antimicrobial resistance in ESKAPE pathogens DMP De Oliveira, BM Forde, TJ Kidd, PNA Harris, MA Schembri, ... Clinical microbiology reviews 33 (3), 10.1128/cmr. 00181-19, 2020 | 1297 | 2020 |
| Global dissemination of a multidrug resistant Escherichia coli clone NK Petty, NL Ben Zakour, M Stanton-Cook, E Skippington, M Totsika, ... Proceedings of the National Academy of Sciences 111 (15), 5694-5699, 2014 | 611 | 2014 |
| Effect of Lactobacillus salivarius Bacteriocin Abp118 on the Mouse and Pig Intestinal Microbiota E Riboulet-Bisson, MHJ Sturme, IB Jeffery, MM O'Donnell, BA Neville, ... PLoS ONE 7 (2), e31113, 2012 | 210 | 2012 |
| Stepwise evolution of pandrug-resistance in Klebsiella pneumoniae HM Zowawi, BM Forde, M Alfaresi, A Alzarouni, Y Farahat, TM Chong, ... Scientific reports 5, 15082, 2015 | 155* | 2015 |
| The Complete Genome Sequence of Escherichia coli EC958: A High Quality Reference Sequence for the Globally Disseminated Multidrug Resistant E. coli O25b … BM Forde, NL Ben Zakour, M Stanton-Cook, MD Phan, M Totsika, ... PloS one 9 (8), e104400, 2014 | 135 | 2014 |
| Identification of IncA/C plasmid replication and maintenance genes and development of a plasmid multilocus sequence typing scheme SJ Hancock, MD Phan, KM Peters, BM Forde, TM Chong, WF Yin, ... Antimicrobial agents and chemotherapy 61 (2), 10.1128/aac. 01740-16, 2017 | 124 | 2017 |
| Next-generation sequencing technologies and their impact on microbial genomics BM Forde, PW O’Toole Briefings in functional genomics 12 (5), 440-453, 2013 | 97 | 2013 |
| Characterization of pro-inflammatory flagellin proteins produced by Lactobacillus ruminis and related motile lactobacilli BA Neville, BM Forde, MJ Claesson, T Darby, A Coghlan, K Nally, ... PLoS One 7 (7), e40592, 2012 | 93 | 2012 |
| Population dynamics of an Escherichia coli ST131 lineage during recurrent urinary tract infection BM Forde, LW Roberts, MD Phan, KM Peters, BA Fleming, CW Russell, ... Nature communications 10 (1), 3643, 2019 | 90 | 2019 |
| Predicting nitroimidazole antibiotic resistance mutations in Mycobacterium tuberculosis with protein engineering BM Lee, LK Harold, DV Almeida, L Afriat-Jurnou, HL Aung, BM Forde, ... PLoS pathogens 16 (2), e1008287, 2020 | 67 | 2020 |
| Transfer of scarlet fever-associated elements into the group A Streptococcus M1T1 clone NL Ben Zakour, MR Davies, Y You, JHK Chen, BM Forde, ... Scientific reports 5 (1), 15877, 2015 | 67 | 2015 |
| Genome sequences and comparative genomics of two Lactobacillus ruminis strains from the bovine and human intestinal tracts BM Forde, BA Neville, MM O’Donnell, E Riboulet-Bisson, MJ Claesson, ... Microbial cell factories 10, 1-15, 2011 | 67 | 2011 |
| Molecular Characterization of a Multidrug Resistance IncF Plasmid from the Globally Disseminated Escherichia coli ST131 Clone MD Phan, BM Forde, KM Peters, S Sarkar, S Hancock, M Stanton-Cook, ... PloS one 10 (4), e0122369, 2015 | 59 | 2015 |
| Genome-Wide Discovery of Genes Required for Capsule Production by Uropathogenic Escherichia coli KGK Goh, MD Phan, BM Forde, TM Chong, WF Yin, KG Chan, GC Ulett, ... MBio 8 (5), 10.1128/mbio. 01558-17, 2017 | 56 | 2017 |
| Mechanisms Involved in Acquisition of blaNDM Genes by IncA/C2 and IncFIIY Plasmids AM Wailan, HE Sidjabat, WK Yam, NF Alikhan, NK Petty, AL Sartor, ... Antimicrobial agents and chemotherapy 60 (7), 4082-4088, 2016 | 54 | 2016 |
| Carbohydrate catabolic flexibility in the mammalian intestinal commensal Lactobacillus ruminis revealed by fermentation studies aligned to genome annotations MM O’Donnell, BM Forde, B Neville, PR Ross, PW O’Toole Microbial cell factories 10, 1-11, 2011 | 53 | 2011 |
| Discovery of mcr-1-Mediated Colistin Resistance in a Highly Virulent Escherichia coli Lineage BM Forde, HM Zowawi, PNA Harris, L Roberts, E Ibrahim, N Shaikh, ... Msphere 3 (5), 10.1128/msphere. 00486-18, 2018 | 51* | 2018 |
| Molecular Characterization of the Multidrug Resistant Escherichia coli ST131 Clone MA Schembri, NL Ben Zakour, MD Phan, BM Forde, M Stanton-Cook, ... Pathogens 4 (3), 422-430, 2015 | 51 | 2015 |
| Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections caused by AmpC β-lactamase–producing Enterobacter spp, Citrobacter freundii … AG Stewart, DL Paterson, B Young, DC Lye, JS Davis, K Schneider, ... Open Forum Infectious Diseases 8 (8), ofab387, 2021 | 49 | 2021 |
| Modifications in the pmrB gene are the primary mechanism for the development of chromosomally encoded resistance to polymyxins in uropathogenic Escherichia coli MD Phan, NTK Nhu, MES Achard, BM Forde, KW Hong, TM Chong, ... Journal of Antimicrobial Chemotherapy 72 (10), 2729-2736, 2017 | 47 | 2017 |
Scott BeatsonThe University of QueenslandVerified email at uq.edu.au
